Aaron Bernstein
Seminars
Tuesday 16th March 2027
Workshop D: Implementing Human & Organizational Performance (HOP) – Moving from Blame to Systems Thinking in Safety Culture
1:00 pm
Transform your safety culture by implementing Human & Organizational Performance principles that shift focus from individual blame to system improvement.
This interactive workshop provides hands-on experience with operational learning tools including leadership walkthroughs, learning teams, and one-on-one coaching techniques that build trust and psychological safety. You’ll practice facilitating learning conversations, develop skills to respond constructively when incidents occur, and create action plans for embedding HOP principles into your daily operations. Gain practical takeaways including conversation guides, learning team facilitation templates, and measurement frameworks to demonstrate culture improvement over time.
Wednesday 17th March 2027
Fireside Chat: Strengthening Process Safety Strategies to Close Capability Gaps, Prioritise Critical Risks & Prevent Serious Incidents
11:00 am
- Discuss the challenge of finding and retaining process safety expertise, including whether to build in-house capability or rely on external consultants
- Explore how to move beyond traditional injury and incident metrics to identify significant potential events and prioritise the highest-consequence risks
- Share approaches to allocating resources towards the hazards with the greatest potential for serious harm, rather than focusing solely on incident frequency
Thursday 18th March 2027
Panel Discussion: Applying Occupational Exposure Banding & Quantitative Exposure Assessment to Strengthen Controls for Potent Compounds & Novel Modalities
11:30 am
- Master occupational exposure banding (OEB) methodologies for categorizing compound potency and determining appropriate control measures
- Learn quantitative exposure assessment techniques including air monitoring, surface contamination evaluation, and biological monitoring programs
- Explore how to establish exposure controls for compounds where toxicological data is limited, particularly for novel therapeutic modalities
